{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:56:59Z","timestamp":1794351419900,"version":"4.9.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32371170"],"award-info":[{"award-number":["32371170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Talents Project of Health Science and Technology Innovation for Young and Middle-aged Investigators in Henan Province","award":["LJRC2024014"],"award-info":[{"award-number":["LJRC2024014"]}]},{"name":"Scientific Research and Innovation Team of the First Affiliated Hospital of Zhengzhou University","award":["QNCXTD2023006"],"award-info":[{"award-number":["QNCXTD2023006"]}],"id":[{"id":"https:\/\/ror.org\/056swr059","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["262300421039"],"award-info":[{"award-number":["262300421039"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Clinical Medical Scientist Program","award":["HNCMS202527"],"award-info":[{"award-number":["HNCMS202527"]}]},{"name":"Zhongyuan Leading Talent in Science and Technology Innovation","award":["264200510052"],"award-info":[{"award-number":["264200510052"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiovascular-kidney-metabolic (CKM) syndrome is an emerging clinical entity that highlights the complex, bidirectional interplay among cardiovascular disease, chronic kidney disease, and metabolic disorders, representing a substantial and growing global health burden. This conceptualization marks a paradigm shift from viewing these conditions in isolation to understanding them as an interconnected disease continuum. Traditional biomarkers face significant limitations in the early detection, risk stratification, and precise management of CKM, necessitating a transition towards an integrated framework that captures its multisystem nature. This review systematically outlines an emerging multidimensional biomarker system encompassing key pathological axes such as metabolism, immuno-inflammation, oxidative stress, and biological aging, offering refined risk assessment beyond conventional metrics. The development of this system is propelled by revolutionary platforms, including accessible sampling techniques (e.g., dried blood spots), advanced in vitro models (e.g., multi-organ-on-a-chip), and multi-omics technologies. These platforms not only facilitate a deeper dissection of the heterogeneous origins and inter-organ crosstalk in CKM but also accelerate the discovery and validation of novel biomarkers. Concurrently, artificial intelligence serves as a pivotal tool for clinical translation, effectively integrating high-dimensional data to transform complex molecular profiles into actionable clinical insights. By enabling the construction of dynamic risk prediction and decision-support systems, this review charts a pathway toward proactive, individualized, and precise prevention and management of CKM syndrome.<\/jats:p>","DOI":"10.1186\/s12933-026-03178-0","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:16:36Z","timestamp":1777180596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Emerging multidimensional biomarker system for cardiovascular-kidney-metabolic syndrome: from multi-omics integration to clinical artificial intelligence"],"prefix":"10.1186","volume":"25","author":[{"given":"Fei-Hong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Kang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Suo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4170-1263","authenticated-orcid":false,"given":"Zhong-Xiuzi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9006-4977","authenticated-orcid":false,"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,26]]},"reference":[{"issue":"20","key":"3178_CR1","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: a Scientific Statement from the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"20","key":"3178_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"12","key":"3178_CR3","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.cmet.2023.10.015","volume":"35","author":"SE Claudel","year":"2023","unstructured":"Claudel SE, Verma A. Cardiovascular-Kidney-Metabolic Syndrome: a step toward multidisciplinary and inclusive care. Cell Metab. 2023;35(12):2104\u20136.","journal-title":"Cell Metab"},{"issue":"6","key":"3178_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.011510","volume":"17","author":"JB Young","year":"2024","unstructured":"Young JB, Eknoyan G. Cardiorenal Syndrome: an evolutionary appraisal. Circ Heart Fail. 2024;17(6):e011510.","journal-title":"Circ Heart Fail"},{"issue":"21","key":"3178_CR5","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome stages in US adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360.","journal-title":"JAMA"},{"issue":"18","key":"3178_CR6","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.jacc.2024.03.368","volume":"83","author":"AMK Minhas","year":"2024","unstructured":"Minhas AMK, Mathew RO, Sperling LS, Nambi V, Virani SS, Navaneethan SD, et al. Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States. J Am Coll Cardiol. 2024;83(18):1824\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3178_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.amjmed.2025.01.031","volume":"138","author":"JE Kim","year":"2025","unstructured":"Kim JE, Joo J, Kuku KO, Downie C, Hashemian M, Powell-Wiley TM, et al. Prevalence, disparities, and mortality of Cardiovascular-Kidney-Metabolic Syndrome in US adults, 2011-2018. Am J Med. 2025;138(6):970-979.e977.","journal-title":"Am J Med"},{"issue":"6","key":"3178_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004629","volume":"22","author":"MK Tsai","year":"2025","unstructured":"Tsai MK, Kao JT, Wong CS, Liao CT, Lo WC, Chien KL, et al. Cardiovascular-Kidney-Metabolic Syndrome and all-cause and cardiovascular mortality: a retrospective cohort study. PLoS Med. 2025;22(6):e1004629.","journal-title":"PLoS Med"},{"key":"3178_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.100985","volume":"22","author":"J Li","year":"2025","unstructured":"Li J, Wei X. Association of Cardiovascular-Kidney-Metabolic Syndrome with all-cause and cardiovascular mortality: a prospective cohort study. Am J Prev Cardiol. 2025;22:100985.","journal-title":"Am J Prev Cardiol"},{"key":"3178_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1612293","volume":"12","author":"J Li","year":"2025","unstructured":"Li J, Xu Z, Lin J, Luo S, Xu S. Associations between Life\u2019s Crucial 9 and severity, all-cause mortality, and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic Syndrome: the mediating role of phenotypic age acceleration. Front Nutr. 2025;12:1612293.","journal-title":"Front Nutr"},{"key":"3178_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2024.118585","volume":"397","author":"N Li","year":"2024","unstructured":"Li N, Li Y, Cui L, Shu R, Song H, Wang J, et al. Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality. Atherosclerosis. 2024;397:118585.","journal-title":"Atherosclerosis"},{"issue":"5","key":"3178_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41581-025-00957-y","volume":"21","author":"EF Carney","year":"2025","unstructured":"Carney EF. Cardiovascular mortality increases with stage of cardiovascular-kidney-metabolic syndrome. Nat Rev Nephrol. 2025;21(5):283.","journal-title":"Nat Rev Nephrol"},{"key":"3178_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101339","volume":"24","author":"Z Cheng","year":"2025","unstructured":"Cheng Z, Xu W, Luo J, Zeng X, Zeng Q, Cao G, et al. Using the American Heart Association\u2019s new \u201ccardiovascular-kidney-metabolic syndrome\u201d metrics to assess life expectancy in US adults: a life table analysis. Am J Prev Cardiol. 2025;24:101339.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"3178_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12889-024-21131-2","volume":"25","author":"Y Cao","year":"2025","unstructured":"Cao Y, Wang W, Xie S, Xu Y, Lin Z. Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study. BMC Public Health. 2025;25(1):10.","journal-title":"BMC Public Health"},{"issue":"3","key":"3178_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2025.05.030","volume":"86","author":"D He","year":"2025","unstructured":"He D, Zhang X, Li C, Yang C, Yu M, Wang J, et al. Rising prevalence of cardiovascular-kidney-metabolic syndrome in China, 2010\u20132019: national cross-sectional surveys. J Am Coll Cardiol. 2025;86(3):213\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"3178_CR16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1681\/ASN.0000000658","volume":"36","author":"Z Xie","year":"2025","unstructured":"Xie Z, Yu C, Cui Q, Zhao X, Zhuang J, Chen S, et al. Global burden of the key components of cardiovascular-kidney-metabolic syndrome. J Am Soc Nephrol. 2025;36(8):1572\u201384.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3178_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12912-025-03944-7","volume":"24","author":"AM Alodhailah","year":"2025","unstructured":"Alodhailah AM, Almutairi M. Evidence-based nursing strategies and quality of life in Saudi CKD patients with cardio-renal-metabolic comorbidities. BMC Nurs. 2025;24(1):1291.","journal-title":"BMC Nurs"},{"issue":"11","key":"3178_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.45309","volume":"7","author":"R Zhu","year":"2024","unstructured":"Zhu R, Wang R, He J, Wang L, Chen H, Niu X, et al. Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health. JAMA Netw Open. 2024;7(11):e2445309.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3178_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02881-8","volume":"24","author":"M Zhou","year":"2025","unstructured":"Zhou M, Sun W, Gao Y, Jiang B, Sun T, Xu R, et al. Metabolomic profiling reveals interindividual metabolic variability and its association with cardiovascular-kidney-metabolic syndrome risk. Cardiovasc Diabetol. 2025;24(1):315.","journal-title":"Cardiovasc Diabetol"},{"key":"3178_CR20","doi-asserted-by":"crossref","unstructured":"Yang M, Su C, Chang X, Wang G, Liu J. Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome. Eur J Prev Cardiol 2025.","DOI":"10.1093\/eurjpc\/zwaf708"},{"key":"3178_CR21","volume":"31","author":"Y Chen","year":"2024","unstructured":"Chen Y, Huang B, Calvert P, Liu Y, Gue Y, Gupta D, et al. Phenotypes of South Asian patients with atrial fibrillation and holistic integrated care management: cluster analysis of data from KERALA-AF Registry. Lancet Reg Health. 2024;31:100507.","journal-title":"Lancet Reg Health"},{"key":"3178_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112327","volume":"226","author":"M Wang","year":"2025","unstructured":"Wang M, Lin W, Liu H, Qian ZM, Chen J, Rao M, et al. Associations between insulin resistance indices and cardiovascular disease in older adults with cardiovascular-kidney-metabolic syndrome stage 0\u20133: the GOLD-Health cohort. Diabetes Res Clin Pract. 2025;226:112327.","journal-title":"Diabetes Res Clin Pract"},{"key":"3178_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120521","volume":"410","author":"MI Ahmad","year":"2025","unstructured":"Ahmad MI, Chevli P, Mirzai S, Spitz JA, Sharma G, Lima J, et al. Association between cardiovascular-kidney-metabolic syndrome, inflammatory biomarkers, and cardiovascular outcomes: insights from the MESA study. Atherosclerosis. 2025;410:120521.","journal-title":"Atherosclerosis"},{"key":"3178_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pcad.2024.10.012","volume":"87","author":"KS Kittelson","year":"2024","unstructured":"Kittelson KS, Junior AG, Fillmore N, da Silva Gomes R. Cardiovascular-kidney-metabolic syndrome - an integrative review. Prog Cardiovasc Dis. 2024;87:26\u201336.","journal-title":"Prog Cardiovasc Dis"},{"issue":"6","key":"3178_CR25","first-page":"751","volume":"56","author":"S Wang","year":"2025","unstructured":"Wang S, Zeng J, Chen Y, Sun F, Ma H, Zhang L, et al. Association between systemic inflammation and worsening renal function in cardiovascular-kidney-metabolic syndrome. Am J Nephrol. 2025;56(6):751\u201361.","journal-title":"Am J Nephrol"},{"issue":"9","key":"3178_CR26","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/oby.24356","volume":"33","author":"Z Yan","year":"2025","unstructured":"Yan Z, Pu X, Chang X, Liu R. Cardiovascular indexes and oxidative balance in advanced cardiovascular-kidney-metabolic syndrome. Obesity (Silver Spring). 2025;33(9):1791\u2013801.","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"3178_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02940-0","volume":"24","author":"MY Tan","year":"2025","unstructured":"Tan MY, Jiang ZN, Li YQ, Li ZY, Niu B. Association of estimated glucose disposition rate with aging acceleration and mortality risk in individuals with cardiovascular-kidney-metabolic syndrome: evidence from two large national population-based studies. Cardiovasc Diabetol. 2025;24(1):402.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-025-01175-9","volume":"24","author":"J Ge","year":"2025","unstructured":"Ge J, Zhu L, Jiang S, Li W, Lin R, Wu J, et al. Association of dietary quality, biological aging, progression and mortality of cardiovascular-kidney-metabolic syndrome: insights from mediation and machine learning approaches. Nutr J. 2025;24(1):105.","journal-title":"Nutr J"},{"key":"3178_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112437","volume":"228","author":"X Qi","year":"2025","unstructured":"Qi X, Sui J, Yang Z, Dahlen A, Zhang K, Wu B. Periodontitis, accelerated biological aging, and advanced stages in Cardiovascular-Kidney-Metabolic syndrome in U.S. Adults: a mediation analysis. Diabetes Res Clin Pract. 2025;228:112437.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"3178_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02852-z","volume":"24","author":"O Janota-Sosi\u0144ska","year":"2025","unstructured":"Janota-Sosi\u0144ska O, Mantovani M, Irlik K, Kwiendacz H, Olejarz A, Pabis P, et al. Diabetic kidney disease phenotypes and the risk of cardiovascular events: the Silesia Diabetes-Heart Project. Cardiovasc Diabetol. 2025;24(1):305.","journal-title":"Cardiovasc Diabetol"},{"key":"3178_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101312","volume":"24","author":"Y Wei","year":"2025","unstructured":"Wei Y, Li J. Association of estimated glucose disposal rate with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: two prospective cohorts. Am J Prev Cardiol. 2025;24:101312.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"3178_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02692-x","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lian W, Wu L, Huang A, Zhang D, Liu B, et al. Joint association of estimated glucose disposal rate and systemic inflammation response index with mortality in cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):147.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02729-1","volume":"24","author":"B Dong","year":"2025","unstructured":"Dong B, Chen Y, Yang X, Chen Z, Zhang H, Gao Y, et al. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0-3 and the development of a machine learning prediction model: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):163.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02842-1","volume":"24","author":"K Liu","year":"2025","unstructured":"Liu K, Hu J, Huang Y, He D, Zhang J. Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank. Cardiovasc Diabetol. 2025;24(1):277.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study. Cardiovasc Diabetol. 2025;24(1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02662-3","volume":"24","author":"J Hong","year":"2025","unstructured":"Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X. Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):98.","journal-title":"Cardiovasc Diabetol"},{"key":"3178_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaf273","author":"Z Fu","year":"2025","unstructured":"Fu Z, Song S, Ji Y, Duan L, Wang Z, Chen Y, et al. Associations between the triglyceride glucose-body roundness index and frailty trajectory in populations with Cardiovascular-Kidney-Metabolic syndrome: a nationwide prospective cohort study. J Gerontol A Biol Sci Med Sci. 2025. https:\/\/doi.org\/10.1093\/gerona\/glaf273.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3178_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2024.100705","volume":"19","author":"DL Garba","year":"2024","unstructured":"Garba DL, Razavi AC, Blumenthal RS, Stone NJ, Polonsky T, Khan SS, et al. Advances in predicting cardiovascular risk: applying the PREVENT equations. Am J Prev Cardiol. 2024;19:100705.","journal-title":"Am J Prev Cardiol"},{"issue":"20","key":"3178_CR39","doi-asserted-by":"publisher","first-page":"e1006","DOI":"10.1161\/CIR.0000000000001307","volume":"151","author":"SS Khan","year":"2025","unstructured":"Khan SS, Breathett K, Braun LT, Chow SL, Gupta DK, Lekavich C, et al. Risk-based primary prevention of heart failure: a scientific statement from the American Heart Association. Circulation. 2025;151(20):e1006\u201326.","journal-title":"Circulation"},{"issue":"1","key":"3178_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11883-025-01320-z","volume":"27","author":"AB Abdul Jabbar","year":"2025","unstructured":"Abdul Jabbar AB, Inam M, Butt N, Khan SS, Sheikh S, Khoja A, et al. Predicting risk of cardiovascular disease EVENTs (PREVENT) equations: what clinicians need to know? Curr Atheroscler Rep. 2025;27(1):73.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"3178_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmet.2024.10.007","volume":"37","author":"S Li","year":"2025","unstructured":"Li S, Liu H, Hu H, Ha E, Prasad P, Jenkins BC, et al. Human genetics identify convergent signals in mitochondrial LACTB-mediated lipid metabolism in cardiovascular-kidney-metabolic syndrome. Cell Metab. 2025;37(1):154-168.e157.","journal-title":"Cell Metab"},{"key":"3178_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2025.156452","volume":"175","author":"S Wei","year":"2026","unstructured":"Wei S, Shu Z, Li X, Zhong S, Xiao L, Shen R, et al. Air pollution exacerbates cardiovascular-kidney-metabolic syndrome and sarcopenia comorbidity via shared genetic-epigenetic mechanisms: a multi-omics and Mendelian Randomization study. Metabolism. 2026;175:156452.","journal-title":"Metabolism"},{"issue":"1","key":"3178_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.125.045148","volume":"15","author":"S Inaba","year":"2026","unstructured":"Inaba S, Hasegawa T, Nakano Y, Naito S, Suzukawa R, Koide T, et al. Circulating extracellular vesicle microRNAs as predictive biomarkers for kidney and cardiovascular events. J Am Heart Assoc. 2026;15(1):e045148.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"3178_CR44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.037454","volume":"14","author":"TA Jacobson","year":"2025","unstructured":"Jacobson TA, Rahbari KJ, Schwartz WA, Bae Y, Zhang R, Nunes DA, et al. Dried blood spots to assess cardiovascular-kidney-metabolic health. J Am Heart Assoc. 2025;14(6):e037454.","journal-title":"J Am Heart Assoc"},{"key":"3178_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2025.180003","volume":"993","author":"Z Zheng","year":"2025","unstructured":"Zheng Z, Xu Y, Kang N, Dong Y, Wang X, Zhang L, et al. Assessing the effect of perfluoroalkyl and polyfluoroalkyl substances on Cardiovascular-Kidney-Metabolic Syndrome: insights from an interpretable machine learning model. Sci Total Environ. 2025;993:180003.","journal-title":"Sci Total Environ"},{"key":"3178_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1597864","volume":"12","author":"J Huang","year":"2025","unstructured":"Huang J, Liu Z, Feng W, Huang Y, Cheng X. Machine learning with decision curve analysis evaluates nutritional metabolic biomarkers for Cardiovascular-Kidney-Metabolic risk: an NHANES analysis. Front Nutr. 2025;12:1597864.","journal-title":"Front Nutr"},{"issue":"11","key":"3178_CR47","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1089\/dia.2025.0216","volume":"27","author":"L Shang","year":"2025","unstructured":"Shang L, Sha S, Hou Y. Evaluating Cardiovascular-Kidney-Metabolic Syndrome knowledge in large language models: a comparative study of ChatGPT, Gemini, and DeepSeek. Diabetes Technol Ther. 2025;27(11):953\u20138.","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"3178_CR48","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1111\/dom.70346","volume":"28","author":"S Duan","year":"2026","unstructured":"Duan S, Wang Y, Yang X, Xu Y, Wang J. Explainable machine learning-driven predictive modelling of incident cognitive impairment in individuals with early-stage Cardiovascular-Kidney-Metabolic Syndrome: insights from a longitudinal CHARLS cohort study. Diabetes Obes Metab. 2026;28(3):1693\u2013709.","journal-title":"Diabetes Obes Metab"},{"key":"3178_CR49","doi-asserted-by":"crossref","unstructured":"Lu Y, Ge J, Zhu L, Wang L, Wu J, Dong F, Deng J. Cardiometabolic-kidney indices and machine learning model for predicting all-cause mortality in patients with cardiovascular-kidney-metabolic syndrome: a longitudinal cohort study. Am J Nephrol. 2025:1\u201328.","DOI":"10.1159\/000549578"},{"issue":"6","key":"3178_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3835","volume":"40","author":"W Liu","year":"2024","unstructured":"Liu W, Wang W, Sun F, Jiang N, Yuan L, Bu X, et al. Machine learning-assisted analysis of sublingual microcirculatory dysfunction for early cardiovascular risk evaluation and Cardiovascular-Kidney-Metabolic Syndrome stage in patients with Type 2 Diabetes Mellitus. Diabetes Metab Res Rev. 2024;40(6):e3835.","journal-title":"Diabetes Metab Res Rev"},{"issue":"8","key":"3178_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004723","volume":"22","author":"J Manne-Goehler","year":"2025","unstructured":"Manne-Goehler J, Venter WDF, Ali MK, Franco JVA. Cardiovascular-kidney-metabolic syndrome: a new frontier or simple rebranding? PLoS Med. 2025;22(8):e1004723.","journal-title":"PLoS Med"},{"issue":"1","key":"3178_CR52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12933-025-02735-3","volume":"24","author":"M Li","year":"2025","unstructured":"Li M, Xu M, Ding Y, Lin H, Qin G, Wang T, et al. Life\u2019s Essential 8 cardiovascular health, Cardiovascular-Kidney-Metabolic Syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China. Cardiovasc Diabetol. 2025;24(1):197.","journal-title":"Cardiovasc Diabetol"},{"key":"3178_CR53","volume":"55","author":"Y Yim","year":"2025","unstructured":"Yim Y, Lee JE, Son Y, Kim S, Lee H, Lee S, et al. Long-term trends in the prevalence of Cardiovascular-Kidney-Metabolic Syndrome in South Korea, 2011\u20132021: a representative longitudinal serial study. Lancet Reg Health West Pac. 2025;55:101474.","journal-title":"Lancet Reg Health West Pac"},{"key":"3178_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.101369","volume":"25","author":"T Xu","year":"2026","unstructured":"Xu T, Wei J, Xu M, Li H, Chen S, Ji H, et al. Cardiovascular-kidney-metabolic syndrome stages and increased risk of all-cause and cause-specific mortality in UK Biobank. Am J Prev Cardiol. 2026;25:101369.","journal-title":"Am J Prev Cardiol"},{"key":"3178_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111926","volume":"218","author":"V Trimarco","year":"2024","unstructured":"Trimarco V, Izzo R, Pacella D, Manzi VM, Trama U, Lembo M, et al. Increased prevalence of cardiovascular-kidney-metabolic syndrome during COVID-19: a propensity score-matched study. Diabetes Res Clin Pract. 2024;218:111926.","journal-title":"Diabetes Res Clin Pract"},{"key":"3178_CR56","doi-asserted-by":"crossref","unstructured":"Gregg LP, Bozkurt B, Navaneethan SD. Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD. Clin J Am Soc Nephrol. 2025.","DOI":"10.2215\/CJN.0000000973"},{"key":"3178_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2024.07.014","volume":"127","author":"M Kanbay","year":"2024","unstructured":"Kanbay M, Guldan M, Ozbek L, Copur S, Covic AS, Covic A. Exploring the nexus: the place of kidney diseases within the cardiovascular-kidney-metabolic syndrome spectrum. Eur J Intern Med. 2024;127:1\u201314.","journal-title":"Eur J Intern Med"},{"issue":"10","key":"3178_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038445","volume":"14","author":"P Xie","year":"2025","unstructured":"Xie P, Wang Y, Xu X, Tan L, Guo X, Xu Z, et al. Association of Cardiovascular-Kidney-Metabolic Syndrome with cognitive decline and dementia: the ARIC Study insights. J Am Heart Assoc. 2025;14(10):e038445.","journal-title":"J Am Heart Assoc"},{"issue":"Pt A","key":"3178_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.120641","volume":"395","author":"Q He","year":"2026","unstructured":"He Q, Sun M, Wang Q, Huang J, Hu S, Shen Y, et al. Cardiovascular-kidney-metabolic syndrome, dementia risk, cognition, and neuroimaging outcomes. J Affect Disord. 2026;395(Pt A):120641.","journal-title":"J Affect Disord"},{"issue":"5","key":"3178_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100112","volume":"12","author":"X Jiang","year":"2025","unstructured":"Jiang X, Bahorik AL, Dintica CS, Yaffe K. Cardiovascular-kidney-metabolic syndrome and incidence of dementia among older adults. J Prev Alzheimers Dis. 2025;12(5):100112.","journal-title":"J Prev Alzheimers Dis"},{"issue":"15","key":"3178_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033291724002381","volume":"54","author":"X Huang","year":"2024","unstructured":"Huang X, Liang J, Zhang J, Fu J, Xie W, Zheng F. Association of cardiovascular-kidney-metabolic health and social connection with the risk of depression and anxiety. Psychol Med. 2024;54(15):1\u20139.","journal-title":"Psychol Med"},{"key":"3178_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1623482","volume":"12","author":"RN Tian","year":"2025","unstructured":"Tian RN, Zhang SX, Zhang N, Wu WJ, Guo HQ, Wang C, et al. Association between the dietary inflammatory index and depressive symptoms in adults with cardiovascular-kidney-metabolic syndrome: evidence of metabolic syndrome as a mediator. Front Nutr. 2025;12:1623482.","journal-title":"Front Nutr"},{"key":"3178_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1620008","volume":"12","author":"W Liu","year":"2025","unstructured":"Liu W, Li Z, Ma P. Association of cardiovascular-kidney-metabolic syndrome with depression and all-cause mortality: a population-based observational study. Front Nutr. 2025;12:1620008.","journal-title":"Front Nutr"},{"key":"3178_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119606","volume":"388","author":"Y He","year":"2025","unstructured":"He Y, Lan L, Liu Y, Liang Y, Hu N, Zhang X. Depression severity as a predictor of cardiovascular-kidney-metabolic syndrome progression and mortality: results from two nationally representative cohort studies. J Affect Disord. 2025;388:119606.","journal-title":"J Affect Disord"},{"key":"3178_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119773","volume":"390","author":"L Lei","year":"2025","unstructured":"Lei L, Qu Y, Bei W. Depression and mortality in population with cardiovascular-kidney-metabolic syndrome. J Affect Disord. 2025;390:119773.","journal-title":"J Affect Disord"},{"key":"3178_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119429","volume":"386","author":"G Wang","year":"2025","unstructured":"Wang G, Wu Y, Chen A, Hu L, Wang Z, Xie X, et al. Association between depressive symptoms and mortality in patients with Cardiovascular-Kidney-Metabolic syndrome: the mediating role of inflammatory biomarkers. J Affect Disord. 2025;386:119429.","journal-title":"J Affect Disord"},{"key":"3178_CR67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jad.2025.04.139","volume":"383","author":"B Zha","year":"2025","unstructured":"Zha B, Cai A, Yu H, Wang Z. Development and validation of a predictive model for depression in patients with advanced stage of Cardiovascular-Kidney-Metabolic syndrome. J Affect Disord. 2025;383:32\u201340.","journal-title":"J Affect Disord"},{"key":"3178_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20852","author":"G Zheng","year":"2025","unstructured":"Zheng G, Zhang Y, Su H, Yang H, Ma Z, Li L, et al. Cardiovascular-Kidney-Metabolic health, genetic predisposition and incident risk of psoriasis. J Eur Acad Dermatol Venereol. 2025. https:\/\/doi.org\/10.1111\/jdv.20852.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3178_CR69","doi-asserted-by":"crossref","unstructured":"Lu J, Gao Y, Shi Y, Yin Z. Is cardiovascular-kidney-metabolic syndrome an important risk factor for psoriasis? J Eur Acad Dermatol Venereol. 2025.","DOI":"10.1111\/jdv.70236"},{"issue":"16","key":"3178_CR70","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.034996","volume":"13","author":"J Li","year":"2024","unstructured":"Li J, Lei L, Wang W, Ding W, Yu Y, Pu B, et al. Social risk profile and Cardiovascular-Kidney-Metabolic syndrome in US adults. J Am Heart Assoc. 2024;13(16):e034996.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"3178_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnha.2025.100504","volume":"29","author":"R Zhu","year":"2025","unstructured":"Zhu R, Wang R, He J, Wang L, Chen H, Wang Y, et al. Associations of Cardiovascular-Kidney-Metabolic syndrome stages with premature mortality and the role of social determinants of health. J Nutr Health Aging. 2025;29(4):100504.","journal-title":"J Nutr Health Aging"},{"issue":"16","key":"3178_CR72","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036518","volume":"13","author":"AK April-Sanders","year":"2024","unstructured":"April-Sanders AK. Integrating Social Determinants of Health in the management of Cardiovascular-Kidney-Metabolic Syndrome. J Am Heart Assoc. 2024;13(16):e036518.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3178_CR73","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/ATVBAHA.124.321629","volume":"45","author":"H Ji","year":"2025","unstructured":"Ji H, Sabanayagam C, Matsushita K, Cheng CY, Rim TH, Sheng B, et al. Sex differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-year US trends and mortality risks-Brief Report. Arterioscler Thromb Vasc Biol. 2025;45(1):157\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"3178_CR74","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/CIRCRESAHA.124.325535","volume":"136","author":"H Ayesh","year":"2025","unstructured":"Ayesh H, Nasser SA, Ferdinand KC, Carranza Leon BG. Sex-specific factors influencing obesity in women: bridging the gap between science and clinical practice. Circ Res. 2025;136(6):594\u2013605.","journal-title":"Circ Res"},{"key":"3178_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118993","volume":"303","author":"J Ma","year":"2025","unstructured":"Ma J, Li P, Tao L, Yang X, Luo Y, Guo X, et al. Environment-wide association study of Cardiovascular-Kidney-Metabolic syndrome based on NHANES 2013\u20132016. Ecotoxicol Environ Saf. 2025;303:118993.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"3178_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23906-7","volume":"25","author":"Z Liang","year":"2025","unstructured":"Liang Z, Qing S, Liang Y, Zhang R, Sun M, Ren Z, et al. Independent and combined relationships between light at night, air pollutants, PM(2.5) components and risk of Cardiovascular-Kidney-Metabolic syndrome: a cohort study. BMC Public Health. 2025;25(1):2632.","journal-title":"BMC Public Health"},{"key":"3178_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118915","volume":"303","author":"S Fan","year":"2025","unstructured":"Fan S, Hu H, Li Y, Deng Y, Wang S, Xian J, et al. Effects of ambient air pollution mixtures and household fuel use on progression to advanced Cardiovascular-Kidney-Metabolic syndrome among middle-aged and older adults. Ecotoxicol Environ Saf. 2025;303:118915.","journal-title":"Ecotoxicol Environ Saf"},{"key":"3178_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118885","volume":"303","author":"Y He","year":"2025","unstructured":"He Y, Zhou X, Huang W, Wu Y, Zhang Z, Jin Y, et al. Cadmium exposure and advanced Cardiovascular-Kidney-Metabolic syndrome: an integrated multi-organ perspective based on epidemiology and adverse outcome pathways. Ecotoxicol Environ Saf. 2025;303:118885.","journal-title":"Ecotoxicol Environ Saf"},{"key":"3178_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1613721","volume":"12","author":"J Liu","year":"2025","unstructured":"Liu J, Song Y, Luo R, Wang S, Pan P, Han L. Association between urinary heavy metals and cardiovascular-kidney-metabolic syndrome: mediating roles of TyG, WWI, and eGFR. Front Nutr. 2025;12:1613721.","journal-title":"Front Nutr"},{"key":"3178_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-25894-0","author":"S Zhang","year":"2025","unstructured":"Zhang S, Tang H, Pan L, Zhou M. Association of metal and metalloid exposure with Cardiovascular-Kidney-Metabolic syndrome: mediation by inflammation, oxidative stress, and aging. BMC Public Health. 2025. https:\/\/doi.org\/10.1186\/s12889-025-25894-0.","journal-title":"BMC Public Health"},{"key":"3178_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.119515","volume":"309","author":"W Wen","year":"2025","unstructured":"Wen W, Liu Z, Li L, Qiu F, Zhang H, Cao Y, et al. Multimodal mechanisms of di (2-ethylhexyl) phthalate-induced cardiovascular-kidney-metabolic syndrome: integrating epidemiology, network toxicology and experimental validation. Ecotoxicol Environ Saf. 2025;309:119515.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"3178_CR82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/publications9010012","volume":"9","author":"R Pranckute","year":"2021","unstructured":"Pranckute R. Web of Science (WoS) and Scopus: the titans of bibliographic information in today\u2019s academic world. Publications. 2021;9(1):59.","journal-title":"Publications"},{"issue":"1","key":"3178_CR83","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11883-025-01358-z","volume":"27","author":"F Askarizadeh","year":"2025","unstructured":"Askarizadeh F, Almahmeed W, Abass KS, Virani S, Sahebkar A. Statins as modulators of epithelial to mesenchymal transition in cardiovascular-kidney-metabolic syndrome: a comprehensive review of mechanisms and therapeutic implications. Curr Atheroscler Rep. 2025;27(1):114.","journal-title":"Curr Atheroscler Rep"},{"key":"3178_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14060701","author":"J Guerrero-Mauvecin","year":"2025","unstructured":"Guerrero-Mauvecin J, Villar-G\u00f3mez N, Mi\u00f1o-Izquierdo L, Povo-Retana A, Ramos AM, Ruiz-Hurtado G, et al. Antioxidant effects of SGLT2 inhibitors on Cardiovascular-Kidney-Metabolic (CKM) Syndrome. Antioxidants Basel. 2025. https:\/\/doi.org\/10.3390\/antiox14060701.","journal-title":"Antioxidants Basel"},{"key":"3178_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/obr.70021","author":"GZ Liao","year":"2025","unstructured":"Liao GZ, He CH, Zhang YH, Zhang J. Addressing the \u201cNitric Oxide Crisis\u201d in Cardiovascular-Kidney-Metabolic Syndrome: therapeutic potential of the inorganic nitrate-nitrite-NO pathway. Obes Rev. 2025. https:\/\/doi.org\/10.1111\/obr.70021.","journal-title":"Obes Rev"},{"issue":"13","key":"3178_CR86","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/eurjpc\/zwaf248","volume":"32","author":"X Ding","year":"2025","unstructured":"Ding X, Tian J, Chang X, Liu J, Wang G. Association between remnant cholesterol and the risk of cardiovascular-kidney-metabolic syndrome progression: insights from the China Health and Retirement Longitudinal Study. Eur J Prev Cardiol. 2025;32(13):1157\u201365.","journal-title":"Eur J Prev Cardiol"},{"issue":"13","key":"3178_CR87","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/eurjpc\/zwaf345","volume":"32","author":"M Miname","year":"2025","unstructured":"Miname M, Santos RD. Remnant cholesterol, the cardiovascular-kidney-metabolic syndrome, and cardiovascular disease: lessons from CHARLS. Eur J Prev Cardiol. 2025;32(13):1166\u20138.","journal-title":"Eur J Prev Cardiol"},{"issue":"7","key":"3178_CR88","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.039751","volume":"14","author":"S Wu","year":"2025","unstructured":"Wu S, Zhu J, Lyu S, Wang J, Shao X, Zhang H, et al. Impact of DNA-Methylation age acceleration on long-term mortality among US adults with cardiovascular-kidney-metabolic syndrome. J Am Heart Assoc. 2025;14(7):e039751.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3178_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02860-z","volume":"24","author":"H Zhang","year":"2025","unstructured":"Zhang H, Huang S, Fang Y, Zhang H, Yang W, Yu M. Insulin resistance assessed by estimated glucose disposal rate predicts cardiovascular disease in stages 0-3 of cardiovascular-kidney-metabolic syndrome: a UK biobank cohort study. Cardiovasc Diabetol. 2025;24(1):360.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR90","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12933-024-02352-6","volume":"23","author":"W Li","year":"2024","unstructured":"Li W, Shen C, Kong W, Zhou X, Fan H, Zhang Y, et al. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic Syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2024;23(1):292.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02921-3","volume":"24","author":"M Chen","year":"2025","unstructured":"Chen M, Guo J, Shangguan Y, Sun Z, He X, Tu Q, et al. Association of the triglyceride-glucose index combined with a body shape index with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome stage 0-3: findings from two prospective cohorts. Cardiovasc Diabetol. 2025;24(1):366.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR92","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12933-025-02854-x","volume":"24","author":"Y Yue","year":"2025","unstructured":"Yue Y, Li P, Sun Z, Murayama R, Li Z, Hashimoto K, et al. Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2025;24(1):301.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02754-0","volume":"24","author":"L Lu","year":"2025","unstructured":"Lu L, Chen Y, Liu B, Li X, Wang J, Nie Z, et al. Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):202.","journal-title":"Cardiovasc Diabetol"},{"key":"3178_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112989","volume":"230","author":"C Zhang","year":"2025","unstructured":"Zhang C, Chen Y, Wang T, Peng W, Ning M, Liu Y. Inflammation and abnormal glucose-lipid metabolism are critical for population stratification toward progressive frailty in Cardiovascular-Kidney-Metabolic Syndrome. Diabetes Res Clin Pract. 2025;230:112989.","journal-title":"Diabetes Res Clin Pract"},{"key":"3178_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1661826","volume":"12","author":"P C","year":"2025","unstructured":"C P, Lui M, Zhang L, Chen C, Wang T, H A, et al. Association of SII and SIRI with incidence of cardiovascular disease in cardiovascular-kidney-metabolic syndrome: a prospective cohort study. Front Nutr. 2025;12:1661826.","journal-title":"Front Nutr"},{"key":"3178_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1594041","volume":"12","author":"Y Xu","year":"2025","unstructured":"Xu Y. Association of neutrophil\/high-density lipoprotein cholesterol ratio with the cardiovascular-kidney-metabolic syndrome and its cardiovascular mortality. Front Nutr. 2025;12:1594041.","journal-title":"Front Nutr"},{"key":"3178_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1595119","volume":"12","author":"X Yin","year":"2025","unstructured":"Yin X, Zou J, Yang J. Altered albumin\/neutrophil to lymphocyte ratio are associated with all-cause and cardiovascular mortality for advanced cardiovascular-kidney-metabolic syndrome. Front Nutr. 2025;12:1595119.","journal-title":"Front Nutr"},{"key":"3178_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1622590","volume":"12","author":"G Wang","year":"2025","unstructured":"Wang G, Li G, Wang P, Zang M, Pu J. Association between albumin to globulin ratio and all-cause and cardiovascular mortality among individuals with cardiovascular-kidney-metabolic syndrome: results from NHANES 2003 to 2018. Front Nutr. 2025;12:1622590.","journal-title":"Front Nutr"},{"key":"3178_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1564368","volume":"12","author":"L Shi","year":"2025","unstructured":"Shi L, Zhang D, Zhang S. Association between oxidative balance score with cardiovascular-kidney-metabolic syndrome and all-cause mortality among US population. Front Nutr. 2025;12:1564368.","journal-title":"Front Nutr"},{"key":"3178_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103588","volume":"81","author":"Y Chen","year":"2025","unstructured":"Chen Y, Wu S, Liu H, Zhong Z, Bucci T, Wang Y, et al. Role of oxidative balance score in staging and mortality risk of cardiovascular-kidney-metabolic syndrome: insights from traditional and machine learning approaches. Redox Biol. 2025;81:103588.","journal-title":"Redox Biol"},{"key":"3178_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1597693","volume":"12","author":"D Xie","year":"2025","unstructured":"Xie D, You F, Yang L, Li C, Liu F. The role of oxidative balance score in cardiovascular-kidney-metabolic syndrome progression and mortality: insights from NHANES 1999-2020. Front Nutr. 2025;12:1597693.","journal-title":"Front Nutr"},{"key":"3178_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1673736","volume":"12","author":"Z Wang","year":"2025","unstructured":"Wang Z, Fang L, Wang L, Zhang J. Non-linear associations and threshold effects of oxidative balance score and composite dietary antioxidant index on frailty risk in patients with Cardiovascular-Kidney-Metabolic Syndrome. Front Nutr. 2025;12:1673736.","journal-title":"Front Nutr"},{"key":"3178_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1600651","volume":"12","author":"Q He","year":"2025","unstructured":"He Q, Hu F, Wei W, Li J, Yu Y, Zhang H. Association between the composite dietary antioxidant index and cardiovascular-kidney-metabolic syndrome among U.S. adults: evidence from NHANES 2007-2018. Front Nutr. 2025;12:1600651.","journal-title":"Front Nutr"},{"key":"3178_CR104","doi-asserted-by":"crossref","unstructured":"Zhang Y, Huang Y, Gan X, Yang S, Zhang Y, Wu Y, Ye Z, Cai X, Chen D, Liang X et al. Pro-inflammatory and pro-oxidant diets and CKD risk across cardiovascular-kidney-metabolic syndrome stages: a multi-omics mediation analysis. Food Funct. 2025.","DOI":"10.1039\/D5FO03952E"},{"key":"3178_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1557491","volume":"12","author":"H Yu","year":"2025","unstructured":"Yu H, Liu Y, Zhang T, Guan Z, Li P. Association between dietary inflammatory index score and cardiovascular-kidney-metabolic syndrome: a cross-sectional study based on NHANES. Front Nutr. 2025;12:1557491.","journal-title":"Front Nutr"},{"issue":"1","key":"3178_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-025-01127-3","volume":"24","author":"C Zhao","year":"2025","unstructured":"Zhao C, Lin M, Yang Y, Yang H, Gao Z, Yan Z, et al. Association between dietary inflammatory index and cardiovascular-kidney-metabolic syndrome risk: a cross-sectional study. Nutr J. 2025;24(1):60.","journal-title":"Nutr J"},{"issue":"1","key":"3178_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02593-z","volume":"24","author":"Y Hu","year":"2025","unstructured":"Hu Y, Liang Y, Li J, Li X, Yu M, Cui W. Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular-Kidney-Metabolic Syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):40.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02589-9","volume":"24","author":"G Zheng","year":"2025","unstructured":"Zheng G, Jin J, Wang F, Zheng Q, Shao J, Yao J, et al. Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with Cardiovascular-Kidney-Metabolic Syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):22.","journal-title":"Cardiovasc Diabetol"},{"issue":"14","key":"3178_CR109","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.039983","volume":"14","author":"Z Liu","year":"2025","unstructured":"Liu Z, Zhou D, Tang Y, Huo G. Association of atherogenic index of plasma with stroke risk in a population with Cardiovascular-Kidney-Metabolic Syndrome stages 0 to 3: the first evidence from the China Health and Retirement Longitudinal Study. J Am Heart Assoc. 2025;14(14):e039983.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3178_CR110","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-025-02732-6","volume":"24","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li W, Zhou H, Zeng H, Jiang J, Wang Q, et al. Association between atherogenic index of plasma and new-onset stroke in a population with Cardiovascular-Kidney-Metabolic Syndrome stages 0\u20133: insights from CHARLS. Cardiovasc Diabetol. 2025;24(1):168.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02784-8","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Wen P, Liao Y, Wu T, Zeng L, Huang Y, et al. Association of atherogenic index of plasma and its modified indices with stroke risk in individuals with Cardiovascular-Kidney-Metabolic Syndrome stages 0-3: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):254.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3178_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02742-4","volume":"24","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Cao Z, Teng J, Lu Q, Huang P, Zhou J. Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic Syndrome. Cardiovasc Diabetol. 2025;24(1):183.","journal-title":"Cardiovasc Diabetol"},{"key":"3178_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1548851","volume":"12","author":"Y Duan","year":"2025","unstructured":"Duan Y, Yang K, Zhang T, Guo X, Yin Q, Liu H. Association between non-highdensity lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Cardiovascular-Kidney-Metabolic Syndrome: evidence from NHANES 2001-2018. Front Nutr. 2025;12:1548851.","journal-title":"Front Nutr"},{"issue":"9","key":"3178_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.70815","volume":"13","author":"D Yu","year":"2025","unstructured":"Yu D, Cheng T, Shi Y, Qiu X, Li G, Yang Y, et al. Association of the dietary index for gut microbiota and Cardiovascular-Kidney-Metabolic Syndrome: the mediation effect of phenotypic and biological age acceleration, BMI, and BRI. Food Sci Nutr. 2025;13(9):e70815.","journal-title":"Food Sci Nutr"},{"key":"3178_CR115","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70387","author":"Z Li","year":"2025","unstructured":"Li Z, Chen M. Serum glycated albumin-to-albumin ratio and mortality risk in cardiovascular-kidney-metabolic syndrome: evidence from NHANES over 15\u2009years. Diabetes Obes Metab. 2025. https:\/\/doi.org\/10.1111\/dom.70387.","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"3178_CR116","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/jamia\/ocz145","volume":"26","author":"MC Lenert","year":"2019","unstructured":"Lenert MC, Matheny ME, Walsh CG. Prognostic models will be victims of their own success, unless\u2026. J Am Med Inform Assoc. 2019;26(12):1645\u201350.","journal-title":"J Am Med Inform Assoc"},{"key":"3178_CR117","doi-asserted-by":"crossref","unstructured":"Su G, Liao B, Guo Y, Yang C, Staplin N. Trends in nephrology: cardiovascular kidney-metabolic syndrome. Nephrol Dial Transplant. 2025.","DOI":"10.1093\/ndt\/gfaf250"},{"issue":"1","key":"3178_CR118","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-med-043024-013325","volume":"77","author":"SB Nicholas","year":"2026","unstructured":"Nicholas SB, Nobakht N, Alicic RZ. Therapeutic considerations in preventing chronic kidney disease. Annu Rev Med. 2026;77(1):347\u201361.","journal-title":"Annu Rev Med"},{"key":"3178_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2026.120645","volume":"414","author":"HA Beydoun","year":"2026","unstructured":"Beydoun HA, Beydoun MA, Tsai J, Tinker LF, Franceschini N, Nudy M, et al. Triglyceride-glucose index and cardiovascular disease by Cardiovascular-Kidney-Metabolic Syndrome and socioeconomic status among postmenopausal women. Atherosclerosis. 2026;414:120645.","journal-title":"Atherosclerosis"},{"key":"3178_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2026.156573","volume":"179","author":"L Liu","year":"2026","unstructured":"Liu L, Cai A, Wu KCH, Xu A, Lip GYH, Cheng Y, et al. Sex differences in Cardiovascular-Kidney-Metabolic Syndrome and new onset cardiovascular outcomes. Metabolism. 2026;179:156573.","journal-title":"Metabolism"},{"issue":"11","key":"3178_CR121","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/CIRCRESAHA.125.325497","volume":"136","author":"C Juguilon","year":"2025","unstructured":"Juguilon C, Khosravi R, Radisic M, Wu JC. In vitro modeling of interorgan crosstalk: multi-organ-on-a-chip for studying Cardiovascular-Kidney-Metabolic Syndrome. Circ Res. 2025;136(11):1476\u201393.","journal-title":"Circ Res"},{"issue":"2","key":"3178_CR122","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.kint.2025.04.025","volume":"108","author":"E Bollinger","year":"2025","unstructured":"Bollinger E, Williams G, Piper ME, Steen K, Neale KT, Chen X, et al. Restoration of branched chain amino acid catabolism improves kidney function in preclinical Cardiovascular-Kidney-Metabolic Syndrome models. Kidney Int. 2025;108(2):310\u20136.","journal-title":"Kidney Int"},{"issue":"Suppl 8(Suppl 8","key":"3178_CR123","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.70044","volume":"27","author":"K Yau","year":"2025","unstructured":"Yau K, Cherney DZI, Odutayo A. Biomarkers for cardiovascular-kidney metabolic syndrome: clinical utility in diagnosis, screening, and treatment. Diabetes Obes Metab. 2025;27(Suppl 8(Suppl 8)):3\u20136.","journal-title":"Diabetes Obes Metab"},{"issue":"13\u201314","key":"3178_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/sim.10307","volume":"44","author":"G Shmueli","year":"2025","unstructured":"Shmueli G. To explain, to predict, or to describe: figuring out the study goal [Commentary on \u201cOn the Uses and Abuses of Regression Models\u201d by Carlin and Moreno-Betancur]. Stat Med. 2025;44(13\u201314):e10307.","journal-title":"Stat Med"},{"issue":"1","key":"3178_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-024-02513-3","volume":"24","author":"WAC van Amsterdam","year":"2024","unstructured":"van Amsterdam WAC, de Jong PA, Verhoeff JJC, Leiner T, Ranganath R. From algorithms to action: improving patient care requires causality. BMC Med Inform Decis Mak. 2024;24(1):111.","journal-title":"BMC Med Inform Decis Mak"},{"key":"3178_CR126","doi-asserted-by":"crossref","unstructured":"Liu JC, Yang R, Feng ZF, Liu BQ, Li Y, Chen YH, Li DR, Zheng WR, Liu N, Gao SY et al. Joint associations of accelerometer-measured physical activity and cardiovascular-kidney-metabolic syndrome stages with the risks of cancer and all-cause mortality. J Natl Cancer Inst. 2025.","DOI":"10.1093\/jnci\/djaf365"},{"issue":"7","key":"3178_CR127","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038674","volume":"14","author":"D Tu","year":"2025","unstructured":"Tu D, Sun J, Wang P, Xu Q, Ma C. Overall sleep quality is associated with advanced stages in patients with Cardiovascular-Kidney-Metabolic Syndrome. J Am Heart Assoc. 2025;14(7):e038674.","journal-title":"J Am Heart Assoc"},{"key":"3178_CR128","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0221-y","volume":"3","author":"RT Sutton","year":"2020","unstructured":"Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020;3:17.","journal-title":"NPJ Digit Med"},{"issue":"9","key":"3178_CR129","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41591-019-0548-6","volume":"25","author":"J Wiens","year":"2019","unstructured":"Wiens J, Saria S, Sendak M, Ghassemi M, Liu VX, Doshi-Velez F, et al. Do no harm: a roadmap for responsible machine learning for health care. Nat Med. 2019;25(9):1337\u201340.","journal-title":"Nat Med"},{"issue":"9","key":"3178_CR130","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1161\/CIR.0000000000001412","volume":"153","author":"LP Palaniappan","year":"2026","unstructured":"Palaniappan LP, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2026 Heart Disease and Stroke Statistics: A report of US and global data from the American Heart Association. Circulation. 2026;153(9):e275\u2013906.","journal-title":"Circulation"},{"issue":"8","key":"3178_CR131","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1210\/clinem\/dgaf295","volume":"110","author":"N Pohlman","year":"2025","unstructured":"Pohlman N, Patel PN, Essien UR, Tang JJ, Joseph JJ. Novel cardiometabolic medications in the Cardiovascular-Kidney-Metabolic Syndrome era. J Clin Endocrinol Metab. 2025;110(8):2105\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3178_CR132","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40618-024-02494-0","volume":"48","author":"D Giugliano","year":"2025","unstructured":"Giugliano D, De Nicola L, Maiorino MI, Esposito K. Semaglutide cuts kidney risk in obesity. J Endocrinol Invest. 2025;48(2):295\u20138.","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"3178_CR133","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41591-024-03264-4","volume":"30","author":"M Vaduganathan","year":"2024","unstructured":"Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, et al. Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes. Nat Med. 2024;30(12):3758\u201364.","journal-title":"Nat Med"},{"issue":"4","key":"3178_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/cph4.70033","volume":"15","author":"D Mathew","year":"2025","unstructured":"Mathew D, Davidson S, Yellon D. HIF-mediated fructose metabolism and disease progression in the Cardiovascular-Kidney-Metabolic Syndrome. Compr Physiol. 2025;15(4):e70033.","journal-title":"Compr Physiol"},{"key":"3178_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14091064","author":"CN Hsu","year":"2025","unstructured":"Hsu CN, Lin YJ, Hou CY, Chen YW, Tain YL. Early-life Hydrogen Sulfide signaling as a target for Cardiovascular-Kidney-Metabolic Syndrome reprogramming. Antioxidants. 2025. https:\/\/doi.org\/10.3390\/antiox14091064.","journal-title":"Antioxidants"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03178-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03178-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03178-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:06:00Z","timestamp":1781654760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03178-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,26]]},"references-count":135,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3178"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03178-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,26]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}